UK Innovate will unite the Office of Technology Commercialization and several other initiatives as the university reveals it launched six new spinouts.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Third Rock Ventures has led a series A round for Abata Therapeutics, launched by the firm to commercialise research from Harvard, MIT, Johns Hopkins, NIH and UZH.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Stablix Therapeutics has launched with $63m in equity financing to commercialise research pioneered in Henry Colecraft’s laboratory at Columbia University.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The UC Berkeley spinout-derived genetic eye disease therapeutics company has launched with fresh funding featuring new and founding investors.

The battery optimisation software spinout of TUM has received the new funding after a UVC Partners-backed series A round closed approximately a year ago.